Health By Kate Sheridan Ginkgo Bioworks, Mammoth Biosciences among winners of NIH’s ‘Shark Tank’ for Covid-19 tests
First Opinion By Jennifer Spotila The NIH is thwarting research on a poorly understood yet serious condition
Exclusive By Sharon Begley and Andrew Joseph New alcohol-advertising research stopped with NIH branch director’s arrival
Exclusive By Sharon Begley NIH rejected a study of alcohol advertising while pursuing industry funding for other research
First Opinion By Jeffrey A. Bluestone, David Beier, and Laurie H. Glimcher The NIH is in danger of losing its edge in creating biomedical innovations
Video By Hyacinth Empinado Watch: She went from drug courier to inmate to researcher marching for science
Politics By Sharon Begley Fearful of a Trump administration, many in research call for a ‘tutorial’ for the president-elect
Politics By Charles Piller New federal rules target woeful public reporting of clinical trial results
Politics By David Nather Obama administration, shifting money to fight Zika, says funds are tapped out
Health By Emily Bazar — Kaiser Health News Government listing of clinical trials doesn’t disclose costs to patients
In the Lab By Sheila Kaplan Columbia University fined nearly $10 million for sending inflated bills to NIH
In the Lab By Sheila Kaplan In clinical trials, for-profit review boards are taking over for hospitals. Should they?